Composition for ameliorating or treating dementia containing 2′-fucosyllactose
US12274708B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2023 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | Nov 14, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method for, preventing, ameliorating or treating dementia by administering a composition containing 2′-fucosyllactose. 2′-FL ameliorates brain damage caused by amyloid beta and neuroinflammation by suppressing or preventing accumulation of the amyloid beta, thus being highly effective in preventing, ameliorating and treating dementia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.